Ginkgo Financial Statements From 2010 to 2025

DNA Stock  USD 8.19  0.02  0.24%   
Ginkgo Bioworks' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Ginkgo Bioworks' valuation are provided below:
Gross Profit
131.3 M
Profit Margin
(1.88)
Market Capitalization
509 M
Enterprise Value Revenue
2.6022
Revenue
180.6 M
We have found one hundred twenty available fundamental trends for Ginkgo Bioworks Holdings, which can be analyzed and compared to other ratios and to its competitors. All investors should make sure to confirm all of Ginkgo Bioworks Holdings regular market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. As of December 30, 2025, Market Cap is expected to decline to about 484.1 M. In addition to that, Enterprise Value is expected to decline to about 395 M

Ginkgo Bioworks Total Revenue

256.83 Million

Check Ginkgo Bioworks financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Ginkgo Bioworks' main balance sheet or income statement drivers, such as Net Interest Income of 21.3 M, Interest Income of 23 M or Depreciation And Amortization of 45.8 M, as well as many indicators such as Price To Sales Ratio of 2.13, Dividend Yield of 0.0 or PTB Ratio of 0.68. Ginkgo financial statements analysis is a perfect complement when working with Ginkgo Bioworks Valuation or Volatility modules.
  
Build AI portfolio with Ginkgo Stock
Check out the analysis of Ginkgo Bioworks Correlation against competitors.

Ginkgo Bioworks Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets1.7 B1.4 B1.1 B
Slightly volatile
Short and Long Term Debt Total491.1 M467.7 M115.9 M
Slightly volatile
Other Current Liabilities31.9 M33.5 M47.6 M
Slightly volatile
Total Current Liabilities126.9 M107.3 M73.7 M
Slightly volatile
Total Stockholder Equity1.1 B716.1 M721.8 M
Slightly volatile
Other Liabilities224.8 M249.3 M172.2 M
Slightly volatile
Net Tangible Assets1.1 B1.8 B800.8 M
Slightly volatile
Property Plant And Equipment Net374.4 M598.2 M186.6 M
Slightly volatile
Accounts Payable10.7 M14.2 M5.7 M
Slightly volatile
Cash962 M561.6 M666.7 M
Slightly volatile
Non Current Assets Total606.7 M774.7 M349 M
Slightly volatile
Non Currrent Assets Other50.2 M55.3 M25.5 M
Slightly volatile
Other Assets44.8 M41.2 M23.3 M
Slightly volatile
Cash And Short Term Investments962 M561.6 M666.7 M
Slightly volatile
Net Receivables40.5 M22.4 M25.8 M
Slightly volatile
Common Stock Shares Outstanding43.5 M51.9 M33.7 M
Slightly volatile
Liabilities And Stockholders Equity1.7 B1.4 B1.1 B
Slightly volatile
Non Current Liabilities Total411.5 M554.1 M253.4 M
Slightly volatile
Capital Surpluse4.3 B6.6 B2.2 B
Slightly volatile
Other Current Assets27.1 M18.7 M16 M
Slightly volatile
Other Stockholder Equity4.5 B6.6 B2.3 B
Slightly volatile
Total Liabilities538.4 M661.4 M327.2 M
Slightly volatile
Total Current AssetsB602.7 M710.7 M
Slightly volatile
Cash And Equivalents962 M561.6 M666.7 M
Slightly volatile
Short Term Debt30.4 M29 M7.1 M
Slightly volatile
Intangible Assets54.1 M72.5 M24 M
Slightly volatile
Common Stock4.3 K4.5 K80.2 K
Pretty Stable
Property Plant Equipment374.2 M598.2 M186.5 M
Slightly volatile
Current Deferred Revenue41.6 M30.6 M32.4 M
Slightly volatile
Capital Lease Obligations255.8 M467.7 M99.3 M
Slightly volatile
Net Invested Capital1.2 B716.1 M709 M
Slightly volatile
Long Term Investments71.2 M48.5 M96.7 M
Slightly volatile
Property Plant And Equipment Gross518 M759 M276.5 M
Slightly volatile
Capital Stock4.8 KK123.7 K
Pretty Stable
Non Current Liabilities Other15.7 M16.6 M19.4 M
Slightly volatile
Net Working Capital728.3 M495.5 M550.9 M
Slightly volatile
Noncontrolling Interest In Consolidated Entity49.6 M55.8 M60.9 M
Slightly volatile
Common Stock Total Equity193.1 K218.5 K170.2 K
Slightly volatile
Deferred Long Term Liabilities192.2 M201 M177.5 M
Slightly volatile

Ginkgo Bioworks Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income23 M38.6 M12.5 M
Slightly volatile
Depreciation And Amortization45.8 M63 M24.5 M
Slightly volatile
Interest Expense89.3 K94 K1.8 M
Slightly volatile
Selling General Administrative233.9 M246.2 M218.2 M
Slightly volatile
Total Revenue256.8 M227 M134.1 M
Slightly volatile
Gross Profit175.8 M188.5 M101.4 M
Slightly volatile
Other Operating Expenses1.3 B786.8 M593.7 M
Slightly volatile
Research Development634.9 M424.1 M310.3 M
Slightly volatile
Total Operating Expenses1.2 B748.3 M561 M
Slightly volatile
Reconciled Depreciation43.3 M63 M23.5 M
Slightly volatile
Non Operating Income Net Other70 M78.8 M85.9 M
Slightly volatile
Selling And Marketing Expenses76.8 M86.4 M94.2 M
Slightly volatile

Ginkgo Bioworks Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation106.7 M112.3 M249.6 M
Slightly volatile
Begin Period Cash Flow924.7 M989.6 M489.7 M
Slightly volatile
Depreciation42.3 M63 M23.1 M
Slightly volatile
Capital Expenditures53.6 M62.5 M34.1 M
Slightly volatile
End Period Cash Flow997.7 M605.7 M682.9 M
Slightly volatile
Change To Netincome2.2 B2.1 B640.5 M
Slightly volatile
Dividends Paid838.8 K882.9 K1.1 B
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio2.132.2445148
Slightly volatile
PTB Ratio0.680.711717.3057
Slightly volatile
Days Sales Outstanding34.2836.079960.9558
Pretty Stable
Book Value Per Share13.1113.798320.5029
Pretty Stable
Stock Based Compensation To Revenue0.470.49480.6991
Slightly volatile
Capex To Depreciation0.940.99241.9033
Slightly volatile
PB Ratio0.680.711717.3057
Slightly volatile
EV To Sales1.741.8312142
Slightly volatile
Inventory Turnover1.1 K1.1 K218
Slightly volatile
Days Of Inventory On Hand0.340.3645.1216
Slightly volatile
Payables Turnover2.582.72073.6769
Slightly volatile
Sales General And Administrative To Revenue1.261.08420.9724
Slightly volatile
Research And Ddevelopement To Revenue2.551.86782.0281
Slightly volatile
Capex To Revenue0.350.27550.3708
Slightly volatile
Cash Per Share10.2810.821418.964
Pretty Stable
Days Payables Outstanding124134246
Slightly volatile
Income Quality0.480.58420.4032
Pretty Stable
Intangibles To Total Assets0.03140.05260.0213
Slightly volatile
Net Debt To EBITDA0.180.19373.1696
Slightly volatile
Current Ratio9.445.619210.9945
Slightly volatile
Tangible Book Value Per Share11.7812.40119.6916
Pretty Stable
Receivables Turnover10.6210.11646.9135
Pretty Stable
Shareholders Equity Per Share20.713.798320.6513
Slightly volatile
Debt To Equity0.690.65320.1382
Slightly volatile
Capex Per Share1.41.20520.9981
Slightly volatile
Revenue Per Share4.644.37513.5248
Slightly volatile
Interest Debt Per Share9.479.01492.6306
Slightly volatile
Debt To Assets0.360.33960.081
Slightly volatile
Operating Cycle34.2836.079966.0522
Pretty Stable
Price Book Value Ratio0.680.711717.3057
Slightly volatile
Days Of Payables Outstanding124134246
Slightly volatile
Ebt Per Ebit1.20.97811.4266
Slightly volatile
Company Equity Multiplier1.221.92371.4441
Pretty Stable
Total Debt To Capitalization0.410.39510.098
Slightly volatile
Debt Equity Ratio0.690.65320.1382
Slightly volatile
Quick Ratio9.435.619210.9884
Slightly volatile
Net Income Per E B T1.10.99911.0037
Slightly volatile
Cash Ratio8.735.235310.4769
Slightly volatile
Days Of Inventory Outstanding0.340.3645.1216
Slightly volatile
Days Of Sales Outstanding34.2836.079960.9558
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio1.411.19571.4109
Slightly volatile
Price To Book Ratio0.680.711717.3057
Slightly volatile
Fixed Asset Turnover0.360.37960.8379
Pretty Stable
Debt Ratio0.360.33960.081
Slightly volatile
Price Sales Ratio2.132.2445148
Slightly volatile
Asset Turnover0.110.16480.1035
Slightly volatile
Gross Profit Margin0.570.83020.7565
Slightly volatile
Price Fair Value0.680.711717.3057
Slightly volatile

Ginkgo Bioworks Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap484.1 M509.6 M9.1 B
Slightly volatile
Enterprise Value395 M415.8 M8.5 B
Slightly volatile

Ginkgo Fundamental Market Drivers

Ginkgo Upcoming Events

6th of March 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
6th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Ginkgo Bioworks Financial Statements

Ginkgo Bioworks stakeholders use historical fundamental indicators, such as Ginkgo Bioworks' revenue or net income, to determine how well the company is positioned to perform in the future. Although Ginkgo Bioworks investors may analyze each financial statement separately, they are all interrelated. For example, changes in Ginkgo Bioworks' assets and liabilities are reflected in the revenues and expenses on Ginkgo Bioworks' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Ginkgo Bioworks Holdings. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Current Deferred Revenue30.6 M41.6 M
Total Revenue227 M256.8 M
Cost Of Revenue38.5 M36.6 M
Stock Based Compensation To Revenue 0.49  0.47 
Sales General And Administrative To Revenue 1.08  1.26 
Research And Ddevelopement To Revenue 1.87  2.55 
Capex To Revenue 0.28  0.35 
Revenue Per Share 4.38  4.64 
Ebit Per Revenue(2.47)(2.59)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Ginkgo Bioworks Holdings offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Ginkgo Bioworks' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Ginkgo Bioworks Holdings Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Ginkgo Bioworks Holdings Stock:
Check out the analysis of Ginkgo Bioworks Correlation against competitors.
You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Ginkgo Bioworks. If investors know Ginkgo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Ginkgo Bioworks listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(6.18)
Revenue Per Share
3.305
Quarterly Revenue Growth
(0.56)
Return On Assets
(0.16)
Return On Equity
(0.50)
The market value of Ginkgo Bioworks Holdings is measured differently than its book value, which is the value of Ginkgo that is recorded on the company's balance sheet. Investors also form their own opinion of Ginkgo Bioworks' value that differs from its market value or its book value, called intrinsic value, which is Ginkgo Bioworks' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Ginkgo Bioworks' market value can be influenced by many factors that don't directly affect Ginkgo Bioworks' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Ginkgo Bioworks' value and its price as these two are different measures arrived at by different means. Investors typically determine if Ginkgo Bioworks is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Ginkgo Bioworks' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.